Molnlycke Health Care AB
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Molnlycke Health Care AB sits in the top decile of US sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count).
Molnlycke Health Care AB: 20 sponsored US clinical trials, 2 recruiting.
Molnlycke Health Care AB sponsors 20 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 15 completed. 4 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Wounds, with 2 trials.
Top-decile sponsor footprint
Molnlycke Health Care AB ranks in the top decile of sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
15 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
20 total, page 1 of 1
A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing
NCT05608317
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
NCT05588583
Interventional Study Exploring the Occurrence of Surgical Site Infections.
NCT06661473
Performance and Safety of Exufiber Ag+ and Exufiber on Partial Thickness Burns
NCT04839523
An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds
NCT05494450
Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method
NCT04654182
Evaluation of Chlorhexidine Gluconate Concentration on Skin of Human Subjects Following Multiple Application Times
NCT04235985
Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds
NCT03662997
Durability of Double-gloving With Biogel® Surgical Gloves When Used by Clinicians/Surgeons
NCT03344354
Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings
NCT03249909
Self-adherent Absorbent Silver Dressing in Adults After Hip or Knee Arthroplasty
NCT03016078
Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings
NCT02962882
A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.
NCT02210208
An Open Single-centre Investigation Evaluating Efficacy in Second Degree Partial Thickness Burns Using a Silicone Contact Layer Containing Silver.
NCT01734317
An Investigation to Evaluate a New Donor Site Dressing in Surgical Burn Patients
NCT01670201
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
NCT01636362
Clinical Utility of a New Silver Gel for Use on Chronic Wounds
NCT01442103
Open, Prosp, Rand. Invest. Evaluating Pain With Mepitel One vs.Bridal Veil and Staples on Split Thickness Skin Grafts
NCT01365273
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
NCT01214811
Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®
NCT00742183
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 3 |
Therapeutic Areas
Where Molnlycke Health Care AB enrollment is open (later-stage tilt)
2 recruiting of 20 indexed (10% open); 15 completed (75%).
Phase mix: 4 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Wounds (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Molnlycke Health Care AB: open-pipeline peers nationwide
Peers matched on 20 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Molnlycke Health Care AB sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 20 trials (± recruiting share)
- 59th Medical Wing · 20 trials · 15% recruiting
- Abiomed · 20 trials · 10% recruiting
- Agency for Healthcare Research and Quality (AHRQ) · 20 trials · 0% recruiting
- Alliance Foundation Trials · 20 trials · 15% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Alzheimer's Disease Cooperative Study (ADCS) · 10% recruiting · 10 trials
- Ascension Health · 10% recruiting · 10 trials
Related
What to do with this Molnlycke Health Care AB page
20 registered trials is a research-attention snapshot, not an endorsement of Molnlycke Health Care AB or any single study.
- 2 of Molnlycke Health Care AB's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Wounds is the condition Molnlycke Health Care AB studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Wounds trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Molnlycke Health Care AB pipeline card: 20 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.